Iradimed Corp. (NASDAQ: IRMD) reported Q1 EPS of $0.14, $0.02 better than the analyst estimate of $0.12. Revenue for the quarter came in at $7 million versus the consensus estimate of $6.9 million.

For earnings history and earnings-related data on Iradimed Corp. (IRMD) click here.